‘Liquid biopsy’ helps diagnose and track brain cancer
Intended for healthcare professionals
Research news Previous     Next

‘Liquid biopsy’ helps diagnose and track brain cancer

Dion Smyth Lecturer-practitioner in cancer and palliative care, Birmingham City University
Kat Keogh

A chemical that assists brain cancer surgery by making tumour cells fluorescent could also help to safely diagnose the disease and monitor its response to treatment, a study suggests.

Cancer Nursing Practice. 18, 6, 12-12. doi: 10.7748/cnp.18.6.12.s10

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more